A high-quality diet that minimizes red meat and processed foods is linked with lower risks of heart attack and stroke in patients with cardiovascular disease, according to a study published today in the European Journal of ...
Apr 21, 2023
0
19
Adverse childhood experiences (ACEs) contribute to reduced vascular function and diminished sleep quality in young adults, according to a study at the University of Iowa. In addition, researchers found that poor sleep efficiency ...
Apr 21, 2023
0
15
A real-world, retrospective analysis by the Family Heart Foundation, a leading non-profit research and advocacy organization, found that high-risk Americans who do not maintain levels of LDL-cholesterol (LDL-C) recommended ...
Mar 21, 2023
0
2
Chronic kidney disease (CKD) is an independent risk factor for heart diseases, such as heart attacks, strokes or heart failure. A new study by investigators from Brigham and Women's Hospital, a founding member of the Mass ...
Mar 8, 2023
0
9
Statins are foundational preventive medications that can improve the prognosis and quality of the lives of patients who have or could develop heart disease. However, the best way to identify those who can benefit from a statin ...
Mar 6, 2023
0
4
For women, peripheral microvascular dysfunction in response to mental stress is associated with adverse cardiovascular events, according to a study published online March 1 in Atherosclerosis, Thrombosis, and Vascular Biology ...
Mar 3, 2023
0
2
A new study found that walking an additional 500 steps, or about one-quarter of a mile, per day was associated with a 14% lower risk of heart disease, stroke or heart failure, according to preliminary research to be presented ...
Mar 2, 2023
0
45
Analyzing the most extensive datasets in the United States, researchers from the Icahn School of Medicine at Mount Sinai have revealed that vaccination against COVID-19 is associated with fewer heart attacks, strokes, and ...
Feb 20, 2023
0
12
People who are discharged after a hospitalization involving sepsis were at greater risk of cardiovascular events, rehospitalization for any cause or death during a maximum follow-up of 12 years compared to those hospitalized ...
Feb 1, 2023
0
5
Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced the risk for hospitalization for any cause in patients with chronic kidney disease (CKD) with and without type 2 diabetes. The findings suggest that ...
Dec 6, 2022
0
5
